Gubra AS 2024 AR2
The report highlights Gubra's outstanding performance in 2024, marked by a 31% organic revenue growth in its contract research organization (CRO) business and positive Phase 1a clinical results for its anti-obesity drug candidate, GUBamy. The company advanced its transition from biotechnology to techbio, utilizing its proprietary streaMLine drug discovery platform and establishing a new TechBio lab. In sustainability, Gubra committed to the Science Based Targets initiative (SBTi) and progressed toward its goals of electric power self-sufficiency by 2025 and becoming carbon-negative and nature-positive by 2030. Additionally, the company maintained equal gender representation on its Board of Directors and other management teams.
Company: Gubra AS
Sector: Health Care
Country: Denmark
Year: 2024
Type: AR2
Pages: 118
Gubra AS
Annual Report
The report highlights Gubra's outstanding performance in 2024, marked by a 31% organic revenue growth in its contract research organization (CRO) business and positive Phase 1a clinical results for its anti-obesity drug candidate, GUBamy. The company advanced its transition from biotechnology to techbio, utilizing its proprietary streaMLine drug discovery platform and establishing a new TechBio lab. In sustainability, Gubra committed to the Science Based Targets initiative (SBTi) and progressed toward its goals of electric power self-sufficiency by 2025 and becoming carbon-negative and nature-positive by 2030. Additionally, the company maintained equal gender representation on its Board of Directors and other management teams.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2024
Reporting Period
Jan 1, 2024 - Dec 31, 2024
Fiscal Year
2024
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Scope 3:
Total Waste
Women on Board
Women in Management
Employees